Kazuhiko Takehara
#139,499
Most Influential Person Now
Researcher
Kazuhiko Takehara's AcademicInfluence.com Rankings
Kazuhiko Takeharacomputer-science Degrees
Computer Science
#6606
World Rank
#6964
Historical Rank
Computational Linguistics
#1177
World Rank
#1191
Historical Rank
Machine Learning
#2202
World Rank
#2230
Historical Rank
Artificial Intelligence
#2470
World Rank
#2511
Historical Rank
Download Badge
Computer Science
Kazuhiko Takehara's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Kazuhiko Takehara Influential?
(Suggest an Edit or Addition)Kazuhiko Takehara's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) (2009) (595)
- Role and interaction of connective tissue growth factor with transforming growth factor‐β in persistent fibrosis: A mouse fibrosis model (1999) (467)
- Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. (1996) (438)
- TGF-β inhibition of endothelial cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression (1987) (333)
- Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. (1997) (319)
- Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity1 (2000) (314)
- Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome (2013) (299)
- Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. (2007) (296)
- Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. (1995) (292)
- Smad6 Is a Smad1/5-induced Smad Inhibitor (2000) (285)
- Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. (2001) (271)
- Matrix/Integrin Interaction Activates the Mitogen-activated Protein Kinase, p44 and p42(*) (1995) (266)
- Guidelines for management of atopic dermatitis (2009) (263)
- Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. (2012) (256)
- Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes. (2006) (252)
- Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. (2011) (244)
- Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. (2000) (243)
- Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy (2012) (223)
- Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. (2002) (220)
- B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. (2006) (208)
- CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. (2002) (204)
- Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients (2007) (178)
- Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. (2000) (175)
- Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. (2004) (172)
- Localized scleroderma is an autoimmune disorder. (2005) (152)
- EGF and TGF‐alpha are potent chemoattractants for endothelial cells and EGF‐like peptides are present at sites of tissue regeneration (1989) (151)
- Ligand-dependent Inhibition of B16 Melanoma Cell Migration and Invasion via Endogenous S1P2 G Protein-coupled Receptor (2003) (150)
- The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy (2009) (150)
- Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. (2001) (149)
- Growth regulation of skin fibroblasts. (2000) (148)
- Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. (1998) (144)
- Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases (2005) (142)
- Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. (2004) (141)
- Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J) (2016) (140)
- Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. (2003) (136)
- Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. (2006) (136)
- Skin disease: a cardinal feature of systemic sclerosis. (2006) (135)
- Antinuclear antibodies in localized scleroderma. (1983) (133)
- Hypothesis: pathogenesis of systemic sclerosis. (2003) (130)
- Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? (2008) (124)
- Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis. (1994) (123)
- Potential roles of interleukin-17A in the development of skin fibrosis in mice. (2012) (123)
- Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. (2009) (122)
- Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis. (2004) (118)
- Interferon alfa down‐regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice (2003) (116)
- Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. (2006) (116)
- Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis. (2005) (116)
- Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis (2001) (116)
- Epidemiological study of patients with systemic sclerosis in Tokyo (2004) (114)
- The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis (2008) (113)
- Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis. (2006) (112)
- Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis (2017) (112)
- Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. (2003) (109)
- Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells (2001) (108)
- Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis. (1997) (107)
- Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor‐β in a mouse fibrosis model (2005) (107)
- Antihistone antibodies in patients with localized scleroderma. (1993) (105)
- Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. (2003) (104)
- Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1. (1995) (101)
- Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis. (2001) (100)
- Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts. (1998) (100)
- Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. (2005) (95)
- Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies (2016) (93)
- Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients. (2008) (93)
- Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy (2007) (93)
- Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis. (1999) (92)
- Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. (2013) (91)
- Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis (2000) (91)
- Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. (1999) (91)
- Association of the FAM167A-BLK region with systemic sclerosis. (2010) (90)
- Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma (1995) (89)
- Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement. (2001) (89)
- Association of distinct clinical subsets with myositis‐specific autoantibodies towards anti‐155/140‐kDa polypeptides, anti‐140‐kDa polypeptides, and anti‐aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single‐centre, cross‐sectional study (2009) (87)
- Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis. (2004) (87)
- CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. (2001) (86)
- Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis (2004) (84)
- BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance (2018) (81)
- Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis. (2003) (80)
- Effects of various growth factors and histamine on cultured keloid fibroblasts. (1995) (80)
- Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. (2007) (80)
- Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity. (2016) (79)
- Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis (2011) (79)
- Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. (2004) (79)
- Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle Involvement (2014) (79)
- Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort (2012) (79)
- Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis. (2004) (79)
- Interaction between GC Box Binding Factors and Smad Proteins Modulates Cell Lineage-specific α2(I) Collagen Gene Transcription* (2001) (78)
- Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis. (2003) (77)
- Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein‐1 in skin fibrosis (2009) (77)
- Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. (2005) (76)
- B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. (2013) (75)
- Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies (2016) (75)
- Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor beta-simultaneous application with basic fibroblast growth factor causes persistent fibrosis. (1997) (74)
- BAFF antagonist attenuates the development of skin fibrosis in tight-skin mice. (2007) (72)
- Serum Levels of Tumor Necrosis Factor and Interleukin-13 Are Elevated in Patients with Localized Scleroderma (2003) (72)
- Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis. (1998) (71)
- Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. (2003) (70)
- Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. (1998) (69)
- Association of STAT4 polymorphism with systemic sclerosis in a Japanese population (2009) (69)
- Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF). (2011) (69)
- The loss of MCP-1 attenuates cutaneous ischemia-reperfusion injury in a mouse model of pressure ulcer. (2008) (69)
- Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. (2005) (69)
- Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. (1994) (69)
- Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis (2017) (68)
- Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis. (2016) (67)
- Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. (2004) (66)
- Autoantibody against matrix metalloproteinase‐3 in patients with systemic sclerosis (2004) (66)
- Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti–RNA Polymerase III Autoantibodies (2015) (65)
- Epidemiological Analysis of Prognosis of 496 Japanese Patients with Progressive Systemic Sclerosis (SSc) (1996) (64)
- Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syndrome-type B patients suggests an over-desquamation of corneocytes. (2006) (63)
- Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor‐β‐induced mouse fibrosis (2008) (62)
- Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF. (2007) (62)
- Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity. (2005) (62)
- Association between nail-fold capillary findings and disease activity in dermatomyositis. (2011) (62)
- Increased serum interleukin 23 in patients with systemic sclerosis. (2008) (61)
- Ultrasound measurement of skin thickness in systemic sclerosis. (1995) (61)
- Sentinel Lymph Node Biopsy in Patients with Extramammary Paget's Disease (2004) (60)
- L-Selectin or ICAM-1 Deficiency Reduces an Immediate-Type Hypersensitivity Response by Preventing Mast Cell Recruitment in Repeated Elicitation of Contact Hypersensitivity1 (2003) (60)
- Anti-DNA topoisomerase IIα autoantibodies in localized scleroderma (2004) (59)
- IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease. (2012) (59)
- Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors (1998) (59)
- Elevated circulating CD40L concentrations in patients with systemic sclerosis. (2004) (59)
- Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ‐specific autoimmune diseases (2007) (57)
- Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis. (2002) (57)
- Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis. (2000) (57)
- Elevated Serum KL-6 Levels in Patients with Systemic Sclerosis: Association with the Severity of Pulmonary Fibrosis (2000) (57)
- p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma (1999) (56)
- The efficacy of self-administered stretching for finger joint motion in Japanese patients with systemic sclerosis. (2006) (55)
- Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis (2002) (55)
- A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis. (2009) (55)
- PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population. (2013) (55)
- Increased Serum Soluble OX40 in Patients with Systemic Sclerosis (2008) (54)
- Quantification of eight tissue kallikreins in the stratum corneum and sweat. (2006) (54)
- Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. (2001) (53)
- Host-derived MCP-1 and MIP-1α regulate protective anti-tumor immunity to localized and metastatic B16 melanoma. (2012) (53)
- A randomized, double-blind, placebo-controlled trial: intravenous immunoglobulin treatment in patients with diffuse cutaneous systemic sclerosis. (2013) (53)
- Serum levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients with systemic sclerosis: association with fibrosis and vascular damage. (2008) (51)
- A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase-Akt pathway activation. (2016) (50)
- Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis. (1995) (50)
- Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay. (2009) (50)
- Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis. (2005) (49)
- Use of Serum Clara Cell 16-kDa (CC16) Levels as a Potential Indicator of Active Pulmonary Fibrosis in Systemic Sclerosis (2011) (48)
- Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse (2007) (48)
- Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis. (2013) (46)
- Letters to Dermatology (1998) (46)
- Renal vascular damage in Japanese patients with systemic sclerosis. (2001) (46)
- Diagnostic criteria, severity classification and guidelines of localized scleroderma (2018) (46)
- Antinuclear antibodies in the relatives of patients with systemic sclerosis (1985) (45)
- Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis. (2009) (45)
- Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines. (1997) (45)
- Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway. (2010) (45)
- European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research (2008) (45)
- Antiphospholipid antibody in localised scleroderma (2003) (44)
- Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population (2008) (44)
- Endothelial selectins regulate skin wound healing in cooperation with L‐selectin and ICAM‐1 (2007) (44)
- Increased Serum Pentraxin 3 in Patients with Systemic Sclerosis (2009) (44)
- Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production. (2011) (43)
- Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases (2006) (42)
- Sweet's syndrome associated with granulocyte colony-stimulating factor. (1998) (42)
- Elevated Serum Insulin-like Growth Factor (IGF-1) and IGF Binding Protein-3 Levels in Patients with Systemic Sclerosis: Possible Role in Development of Fibrosis (2008) (42)
- Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis (2018) (40)
- Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma. (1994) (40)
- Clinical evaluation of scleroderma spectrum disorders using a points system (1992) (40)
- Egr-1 Induces a Profibrotic Injury/Repair Gene Program Associated with Systemic Sclerosis (2011) (40)
- Clinical significance of serum levels of soluble interleukin‐2 receptor in patients with localized scleroderma (1996) (40)
- Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis (2005) (39)
- FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin. (2013) (39)
- Regulation of local and metastatic host‐mediated anti‐tumour mechanisms by l‐selectin and intercellular adhesion molecule‐1 (2006) (38)
- Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels (2005) (37)
- erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget's disease. (1999) (37)
- Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis. (2010) (37)
- Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis. (2007) (37)
- Serum levels of CCL17/TARC in various skin diseases (2006) (37)
- Familial clustering of scleroderma spectrum disease. (1988) (37)
- Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease. (2014) (36)
- Investigations of IgG4-related disease involving the skin (2013) (35)
- Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: soluble L-selectin levels indicate disease severity. (1999) (35)
- Relative contributions of selectins and intercellular adhesion molecule-1 to tissue injury induced by immune complex deposition. (2003) (35)
- Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis. (2008) (35)
- Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein. (2007) (35)
- A Clue for Telangiectasis in Systemic Sclerosis: Elevated Serum Soluble Endoglin Levels in Patients with the Limited Cutaneous Form of the Disease (2006) (35)
- Management of Squamous Cell Carcinoma in a Patient with Recessive‐Type Epidermolysis Bullosa Dystrophica (2004) (34)
- High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis (2012) (34)
- Demonstration of interleukin 8 in serum samples of patients with localized scleroderma. (1994) (34)
- Tumour cells of extramammary Paget's disease do not show either p53 mutation or allelic loss at several selected loci implicated in other cancers. (1997) (34)
- Serum Adhesion Molecule Levels as Prognostic Markers in Patients with Early Systemic Sclerosis: A Multicentre, Prospective, Observational Study (2014) (34)
- Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study (2012) (34)
- Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients. (1998) (33)
- Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations. (2005) (33)
- Dermatofibrosarcoma protuberans: increased growth response to platelet-derived growth factor BB in cell culture. (1993) (33)
- The Cutaneous Reverse Arthus Reaction Requires Intercellular Adhesion Molecule 1 and L-Selectin Expression1 (2002) (33)
- Esophageal hypomotility in systemie sclerosis: Close relationship with pulmonary involvement (2001) (33)
- IgG4-Related Skin Disease, a Mimic of Angiolymphoid Hyperplasia with Eosinophilia (2012) (33)
- Amelanotic metastatic melanoma in a patient with oculocutaneous albinism. (1993) (32)
- Skin distribution and differential expression of transforming growth factor β1 and β2 (1992) (31)
- Elevated plasma endothelin levels in systemic sclerosis (2004) (31)
- Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage (2009) (31)
- Antigen specificity of antihistone antibodies in localized scleroderma. (1994) (30)
- Genetic changes in sweat gland carcinomas (2000) (30)
- Coexistence of morphea and systemic sclerosis. (1993) (30)
- Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma. (2000) (30)
- Elevated serum L‐selectin levels and decreased L‐selectin expression on CD8+ lymphocytes in systemic sclerosis (2001) (30)
- Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma. (1990) (30)
- Augmented production of transforming growth factor-β by cultured peripheral blood mononuclear cells from patients with systemic sclerosis (2004) (30)
- Treatment of early diffuse cutaneous systemic sclerosis patients in Japan by low-dose corticosteroids for skin involvement. (2004) (29)
- Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation. (1996) (29)
- Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis. (2005) (29)
- Increased serum soluble CD40 levels in patients with systemic sclerosis. (2007) (28)
- Antibodies to centromere and centriole in scleroderma spectrum disorders. (1994) (28)
- Antinucleosome antibody is a major autoantibody in localized scleroderma (2004) (28)
- Implications of Popliteal Lymph Node Detected by Sentinel Lymph Node Biopsy (2005) (28)
- Expression of Structurally Unaltered Androgen Receptor in Extramammary Paget's Disease (2000) (28)
- Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor beta--simultaneous application with basic fibroblast growth factor causes persistent fibrosis. (1997) (28)
- Simultaneous measurement of serum 5-S-cysteinyldopa, circulating intercellular adhesion molecule-1 and soluble interleukin-2 receptor levels in Japanese patients with malignant melanoma (1997) (27)
- Dipyridamole specifically decreases platelet-derived growth factor release from platelets. (1990) (26)
- Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma. (2004) (26)
- Diagnostic criteria, severity classification and guidelines of systemic sclerosis (2018) (26)
- Antigen specificity of antihistone antibodies in systemic sclerosis (1998) (25)
- The growth regulation of neurofibroma cells in neurofibromatosis type-1: increased responses to PDGF-BB and TGF-beta 1. (1994) (25)
- Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis. (2000) (25)
- Dermokine inhibits ELR(+)CXC chemokine expression and delays early skin wound healing. (2013) (25)
- Epstein–Barr virus‐associated T‐cell lymphoma: a case of eyelid swelling and intramuscular infiltration mimicking dermatomyositis (2002) (25)
- Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis. (2010) (25)
- A Case of Acute Cutaneous Graft-versus-Host Disease Mimicking Psoriasis Vulgaris (2007) (25)
- Systemic Sclerosis Revealing T-Cell Lymphoma (1999) (24)
- B cells promote tumor immunity against B16F10 melanoma. (2014) (24)
- Localised vulva Langerhans cell histiocytosis. (2004) (24)
- No evidence of deregulated patched-hedgehog signaling pathway in trichoblastomas and other tumors arising within nevus sebaceous. (2001) (24)
- Elevated Circulating TWEAK Levels in Systemic Sclerosis: Association with Lower Frequency of Pulmonary Fibrosis (2009) (24)
- Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis. (1996) (24)
- Tape stripping induces marked epidermal proliferation and altered TGF-alpha expression in non-lesional psoriatic skin. (1997) (24)
- Intercellular Adhesion Molecule-1 Deficiency Attenuates the Development of Skin Fibrosis in Tight-Skin Mice1 (2007) (24)
- IgG4-related skin lesions in a patient with IgG4-related chronic sclerosing dacryoadenitis and sialoadenitis. (2011) (24)
- Dipyridamole Decreases Platelet‐Derived Growth Factor Levels in Human Serum (1987) (24)
- Transforming growth factor‐β isoforms differently stimulate proα2 (I) collagen gene expression during wound healing process in transgenic mice (2002) (24)
- Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines. (2012) (23)
- Diagnostic significance of nailfold bleeding in scleroderma spectrum disorders. (1993) (23)
- The Transcriptional Cofactor Nab2 Is Induced by TGF-β and Suppresses Fibroblast Activation: Physiological Roles and Impaired Expression in Scleroderma (2009) (23)
- Long‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab (2018) (23)
- Autoantibody‐mediated regulation of B cell responses by functional anti‐CD22 autoantibodies in patients with systemic sclerosis (2009) (23)
- Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis (2008) (23)
- Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01 (2016) (22)
- Soluble CD4 and CD8 in serum from patients with localized scleroderma (1996) (22)
- Role of C‐C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein‐1α in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production (2004) (22)
- Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis (2004) (22)
- P‐selectin glycoprotein ligand‐1 is required for the development of cutaneous vasculitis induced by immune complex deposition (2004) (21)
- Myocardial damages in systemic sclerosis detected by gated myocardial perfusion SPECT and sympathetic imaging. (2006) (21)
- Regulatory B1a Cells Suppress Melanoma Tumor Immunity via IL-10 Production and Inhibiting T Helper Type 1 Cytokine Production in Tumor-Infiltrating CD8+ T Cells. (2019) (21)
- Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma. (1994) (21)
- A phase III, multicenter, collaborative, open-label clinical trial of sildenafil in Japanese patients with pulmonary arterial hypertension. (2011) (21)
- Autoantibodies directed against the protease inhibitor calpastatin in psoriasis (2005) (21)
- Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis. (2003) (21)
- Two cases of unusual acral melanocytic tumors: illustration of molecular cytogenetics as a diagnostic tool. (2003) (21)
- Melanoma inhibitory activity (MIA) as a serum marker for early detection of post-surgical relapse in melanoma patients: comparison with 5-S-cysteinyldopa (2002) (21)
- Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy. (1996) (21)
- Mapping of occult melanoma micrometastases in the inguinal lymph node basin by immunohistochemistry and RT-PCR. (1999) (20)
- Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Possible role of anti-E1 alpha antibody as a serologic indicator for development of primary biliary cirrhosis. (1995) (20)
- The Frequency of Type 2 CD8+ T Cells Is Increased in Peripheral Blood from Patients with Psoriasis Vulgaris (2003) (20)
- High frequency of DNA aneuploidy detected by DNA flow cytometry in Bowen's disease. (1999) (20)
- Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis. (2013) (20)
- Weekly low‐dose docetaxel in the treatment of lung metastases from angiosarcoma of the head (2005) (20)
- Role of intercellular adhesion molecule‐1 in a murine model of toluene diisocyanate‐induced asthma (2006) (19)
- Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE. (2004) (19)
- L‐selectin and intercellular adhesion molecule‐1 regulate the development of Concanavalin A‐induced liver injury (2006) (19)
- Alu‐mediated large deletion of the CDSN gene as a cause of peeling skin disease (2014) (19)
- E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis. (2006) (18)
- Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis (2004) (18)
- Immunohistochemical analysis of platelet‐derived growth factor and its receptors in fibrohistiocytic tumors (1997) (18)
- Serum CXCL16 Concentrations Correlate with the Extent of Skin Sclerosis in Patients with Systemic Sclerosis (2009) (18)
- Alteration of the chemotactic response of human skin fibroblasts to PDGF by growth factors. (1994) (18)
- Antiphospholipid antibodies in patients with autoimmune blistering disease. (2007) (18)
- Impaired growth response to endothelin-1 in scleroderma fibroblasts. (1995) (17)
- Altered expression of dermokine in skin disorders (2013) (17)
- Early detection of scleroderma spectrum disorders in patients with Raynaud's phenomenon. (1991) (17)
- Identification of Myocardial Damage in Systemic Sclerosis: A Nuclear Cardiology Approach (2010) (17)
- Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis. (1990) (17)
- Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma. (2004) (17)
- Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis. (2001) (16)
- Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma (2005) (16)
- Lymphatic mapping and sentinel lymph node biopsy for staging of aggressive digital papillary adenocarcinoma. (2006) (16)
- Clonal heterogeneity in sporadic melanomas as revealed by loss‐of‐heterozygosity analysis (2000) (16)
- Drug‐Induced Hypersensitivity Syndrome Associated with Human Herpesvirus 6 and Cytomegalovirus Reactivation (2005) (16)
- A Crucial Role of L‐Selectin in C Protein–Induced Experimental Polymyositis in Mice (2014) (16)
- Subtraction method for determination of N-terminal connective tissue growth factor (2010) (16)
- The diagnostic value of oesophageal transit scintigraphy for evaluating the severity of oesophageal complications in systemic sclerosis (2004) (16)
- Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease. (2017) (16)
- Clonal expansion of Epstein–Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions (2012) (16)
- Adipose‐derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models (2019) (16)
- Comparison of anti-OJ antibody detection assays between an immunoprecipitation assay and line blot assay (2017) (16)
- Bullous pemphigoid with a prolonged prodrome (2008) (16)
- Increase in plasma thrombomodulin in patients with systemic sclerosis. (1993) (15)
- Detection of antiribosomal P protein antibodies in patients with systemic sclerosis. (1995) (15)
- Pigmented Dermatofibrosarcoma protuberans (Bednář Tumor) Occurring in a Japanese Infant (1998) (15)
- An update on biomarker discovery and use in systemic sclerosis (2017) (15)
- Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies (2020) (15)
- Genital herpes due to acyclovir‐sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase‐deficient/temperature‐sensitive virus (2007) (15)
- Coexistence of micrometastatic melanoma cells and sarcoid granulomas in all regional lymph nodes in a patient with acral melanoma (2003) (15)
- Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population (2019) (14)
- Transforming growth factor-beta isoforms differently stimulate proalpha2 (I) collagen gene expression during wound healing process in transgenic mice. (2002) (14)
- Absence of human herpesvirus‐8 DNA in angiosarcmas and other skin tumours in immnocompetent patients, and in graft‐versus‐host disease in the immunosuppressed recipients of bone marrow transplants (1997) (14)
- Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud's phenomenon. (2015) (14)
- Autoantibodies to a collagen‐specific molecular chaperone, heat‐shock protein 47, in systemic sclerosis (2004) (14)
- Circulating γ/δ T cells in systemic sclerosis exhibit activated phenotype and enhance gene expression of proalpha2(I) collagen of fibroblasts. (2013) (14)
- Phase-dependent roles of E-selectin during chronic contact hypersensitivity responses. (2007) (14)
- Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma. (2006) (14)
- Intractable genital ulcers from herpes simplex virus reactivation in drug‐induced hypersensitivity syndrome caused by allopurinol (2010) (14)
- Elevated levels of circulating CD44 in patients with systemic sclerosis: association with a milder subset. (2002) (14)
- Serum TARC/CCL 17 Levels as a Disease Marker of Atopic Dermatitis (2006) (14)
- Ascorbate effects on type I procollagen synthesis by human adult skin fibroblasts: different migration positions of type I procollagen chains on SDS polyacrylamide gel after incubation with ascorbate. (1987) (13)
- Anti-nuclear autoantibodies in systemic sclerosis : News and perspectives (2018) (13)
- CCL13 is a promising diagnostic marker for systemic sclerosis (2010) (13)
- Atypical scleroderma associated with multiple myeloma. (1989) (13)
- Successful treatment with sildenafil in systemic sclerosis patients with isolated pulmonary arterial hypertension: two case reports (2005) (13)
- Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study. (2012) (13)
- Antinuclear antibodies in localized scleroderma: unique staining in chromosome spreads. (1989) (13)
- Anti‐transcriptional intermediary factor 1‐γ antibody as a biomarker in patients with dermatomyositis (2020) (13)
- Longitudinal study of patients with anticentromere antibody. (1990) (12)
- Response of scleroderma fibroblasts to various growth factors (2004) (12)
- A case of malignant hypertension and scleroderma after cosmetic surgery. (1991) (12)
- Diagnostic criteria, severity classification and guidelines of lichen sclerosus et atrophicus (2018) (12)
- Intercellular Adhesion Molecule-1 Deficiency Attenuates the Development of Skin Fibrosis in Tight-Skin Mice (2007) (12)
- Differential chemotactic responses mediated by platelet-derived growth factor alpha- and beta-receptors. (1995) (12)
- Intercellular adhesion molecule‐1 and vascular cell adhesion molecule‐1 cooperatively contribute to the cutaneous Arthus reaction (2007) (12)
- High incidence of pulmonary arterial hypertension in systemic sclerosis patients with anti-centriole autoantibodies (2015) (12)
- Hereditary non‐polyposis colorectal cancer associated with disseminated superficial porokeratosis. Microsatellite instability in skin tumours (2000) (12)
- Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti‐topoisomerase I antibodies and those with anticentromere antibody (2008) (12)
- Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open‐label study (2017) (12)
- Reactive hemophagocytic syndrome in a patient with polyarteritis nodosa associated with Epstein–Barr virus reactivation (2006) (11)
- Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis (1994) (11)
- Skin distribution and differential expression of transforming growth factor beta 1 and beta 2. (1992) (11)
- Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease (2019) (11)
- The effects of various growth factors on endothelial cell survival in vitro. (1989) (10)
- Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod (2019) (10)
- Dipyridamole specifically decreases platelet-derived growth factor release from platelets. (1990) (10)
- Idiopathic Intracranial Hypertension with Elevated Cerebrospinal Fluid Level of Interleukin-6 in a Patient with Systemic Lupus Erythematosus (2002) (10)
- Elevated soluble CD23 levels in the sera from patients with localized scleroderma (1996) (10)
- Antiubiquitin antibody in localised and systemic scleroderma. (1996) (10)
- Anti-DNA topoisomerase II α autoantibodies in Japanese patients with systemic sclerosis (2005) (10)
- Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial (2020) (10)
- A case of aseptic meningitis without neck rigidity occurring in a metastatic melanoma patient treated with ipilimumab (2017) (10)
- Elevated serum levels of soluble L-selectin in patients with systemic sclerosis declined after intravenous injection of lipo-prostaglandin E1. (2001) (10)
- Anti‐topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis (2013) (10)
- Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction. (2009) (9)
- Association of UBE2L3 polymorphisms with diffuse cutaneous systemic sclerosis in a Japanese population (2012) (9)
- Basophils and mast cells play critical roles for leukocyte recruitment in IgE-mediated cutaneous reverse passive Arthus reaction. (2012) (9)
- Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis. (2010) (9)
- Four cases of anti‐Mi‐2 antibody‐positive dermatomyositis: relationship between anti‐Mi‐2 antibody titre and disease severity and activity (2018) (9)
- Phenotypic analysis in a case of hydroa vacciniforme‐like eruptions associated with chronic active Epstein–Barr virus disease of γδ T cells (2012) (9)
- Elevated serum placenta growth factor (PlGF) levels in patients with systemic sclerosis: a possible role in the development of skin but not lung fibrosis. (2010) (9)
- Increased expression levels of FcγRIIB on naïve and double-negative memory B cells in patients with systemic sclerosis. (2019) (9)
- Autoantibody to transcriptional intermediary factor‐1β as a myositis‐specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy (2018) (8)
- Clinical distribution of anticentromere antibody in Japanese patients. (1989) (8)
- Transforming growth factor‐β signaling is differentially inhibited by Smad2D450E and Smad3D407E (2004) (8)
- Esophageal transit scintigraphy and structured questionnaire in patients with systemic sclerosis with endoscopically proven reflux esophagitis (2009) (8)
- Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis (2004) (8)
- Clinical and laboratory features dependent on age at onset in Japanese systemic sclerosis (2013) (8)
- Up regulated expression of fractalkine / CX 3 CL 1 and CX 3 CR 1 in patients with systemic sclerosis (2004) (8)
- A case of scleroderma spectrum disorder with anticentriole antibody and pulmonary hypertension (2004) (8)
- Clinical characteristics of juvenile systemic sclerosis in Japanese. (2005) (8)
- Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension. (2009) (7)
- Autoantibodies against calpastatin in sera from patients with systemic sclerosis. (1998) (7)
- 022 Serum levels of interleukin-4, interleukin-10, and interleukin-13 in patients with systemic sclerosis (1996) (7)
- Long-term follow-up of finger passive range of motion in Japanese systemic sclerosis patients treated with self-administered stretching (2019) (7)
- Food‐dependent exercise‐induced anaphylaxis due to shrimp associated with 43 kDa, a new antigen (2018) (7)
- The stimulatory effects of PDGF and TGF-beta 1 on dermal fibroblast attachment. (1995) (7)
- Skin sclerosis as a manifestation of POEMS syndrome (2012) (7)
- A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies. (1993) (7)
- Systemic sclerosis associated with multiple sclerosis. (1989) (7)
- Alteration of the Chemotactic Response of Human Skin Fibroblasts to PDGF by Growth Factors (1992) (7)
- Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc. (2001) (7)
- Hereditary type IIb protein S deficiency in a patient with recurrent venous ulcers. (1997) (7)
- CD22 and CD72 contribute to the development of scleroderma in a murine model. (2019) (6)
- Stevens–Johnson syndrome associated with radiation recall dermatitis in a patient treated with immune checkpoint inhibitor (2019) (6)
- Expression Correlates with Autoimmunity Quantitative Genetic Variation in CD19 (2000) (6)
- Advances in Brief Loss of Expression of the Metastasis Suppressor Gene KiSS 1 during Melanoma Progression and Its Association with LOH of Chromosome 6 q 16 . 3q 231 (2001) (6)
- Soluble CD163 is a potential biomarker in systemic sclerosis (2019) (6)
- A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor (2020) (6)
- Accumulation of mature B cells in the inflamed muscle tissue of a patient with anti-155/140 antibody-positive juvenile dermatomyositis (2013) (6)
- Successful Treatment with Bosentan for Pulmonary Hypertension and Reduced Peripheral Circulation in Juvenile Systemic Sclerosis (2011) (6)
- A case of juvenile systemic sclerosis with disease onset at six months old (2003) (6)
- Autoantibodies to the heat-shock protein hsp73 in localized scleroderma (1995) (6)
- Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis. (2020) (6)
- Systemic lupus erythematosus associated with antiribosomal P protein antibody. (1990) (5)
- Performance evaluation of a line blot assay system for detection of anti‐PM‐Scl antibody in Japanese patients with systemic sclerosis (2019) (5)
- Prurigo nodularis-like skin eruptions in a patient with IgG4-related disease. (2013) (5)
- Elevated procollagen type I carboxyterminal propeptide production in cultured scleroderma fibroblasts. (1995) (5)
- ABNORMAL AND UNSTABLE PATTERNS OF THE DNA OF STROMA CELLS IN A PATIENT WITH TUBEROUS SCLEROSIS (1984) (5)
- Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients (2020) (5)
- DISTURBED MITOTIC PROCESSES OF STROMA CELLS IN A PATIENT WITH TUBEROUS SCLEROSIS (1984) (5)
- Ultraviolet Light Exposure Suppresses Contact Hypersensitivity by Abrogating Endothelial Intercellular Adhesion Molecule-1 Up-Regulation at the Elicitation Site 1 (2003) (5)
- A case of anti-RuvBL1/2 antibody-positive systemic sclerosis overlapping with myositis (2020) (5)
- ABNORMAL DNA HISTOGRAMS OF STROMA CELLS IN PATIENTS WITH TUBEROUS SCLEROSIS (1984) (5)
- Total Androgen Blockade Therapy for an Advanced case of Extramammary Paget's carcinoma. (2001) (5)
- An ultrastructural observation of the facial lesion in pringles disease (1981) (4)
- The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients (2013) (4)
- Decreased expression levels of CD22 and L-selectin on peripheral blood B lymphocytes from patients with bullous pemphigoid. (2006) (4)
- Increased interleukin‐9 levels in sera, muscle and skin of patients with dermatomyositis (2018) (4)
- Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc (2017) (4)
- Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc‐related autoantibodies: A single‐center retrospective study (2020) (4)
- Two cases of livedo vasculopathy with non‐criteria antiphospholipid antibodies (2012) (4)
- Initial predictors of skin thickness progression in patients with diffuse cutaneous systemic sclerosis: Results from a multicentre prospective cohort in Japan (2020) (3)
- CD22 and CD72 cooperatively contribute to the development of the reverse Arthus reaction model. (2019) (3)
- Human leukocyte antigen in Japanese patients with idiopathic inflammatory myopathy (2020) (3)
- Esophageal transit study using a sliding sum image: application to patients with probable and definite systemic sclerosis (2011) (3)
- Clinical association of serum CD137 (4-1BB) levels in patients with systemic sclerosis. (2009) (3)
- Supportive care for hand-foot syndrome and stomatitis in relapsed ovarian cancer patients receiving pegylated liposomal doxorubicin. (2011) (3)
- Rosai-Dorfman disease presenting as large pigmented indurated plaques. (2003) (3)
- Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodies (2007) (3)
- Increased plasma granulocyte elastase levels in Behçet's disease. (1998) (3)
- RXRB Is an MHC-Encoded Susceptibility Gene Associated with Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis. (2017) (3)
- Clinical significance of antinuclear matrix antibody in serum from patients with anti-U1RNP antibody (2000) (3)
- The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients (2014) (3)
- Autoantibody to scaffold attachment factor B (SAFB): A novel connective tissue disease-related autoantibody associated with interstitial lung disease. (2017) (3)
- Clinical course of Japanese patients with early systemic sclerosis: A multicenter, prospective, observational study (2020) (2)
- Chromoblastomycosis caused by Phialophora verrucosa on the hand (2015) (2)
- Two cases of primary malignant melanoma of the esophagus (2017) (2)
- Angiosarcoma-related pneumohemothorax treated with intrapleural paclitaxel administration and pleurodesis with OK-432 (2018) (2)
- Case of anti‐transcriptional intermediary factor‐1‐positive dermatomyositis associated with breast cancer developing over 10 years (2017) (2)
- Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis. (2005) (2)
- Mitogenic activities for skin fibroblasts in the sera from untreated scleroderma patients at the early stage (2004) (2)
- Long‐term changes in nail fold capillary abnormalities and serum fibroblast growth factor 23 levels in dermatomyositis patients with anti‐melanoma differentiating antigen 5 antibody (2020) (2)
- Cutaneous necrotizing vasculitis in a patient with dermatomyositis positive for anti-PL-7 antibody. (2013) (2)
- The effects of scleroderma sera on endothelial cell survival in vitro (2004) (2)
- [An explant culture of the facial lesions in Pringle's disease (author's transl)]. (1981) (2)
- A role for FcγRIIB in the development of murine bleomycin-induced fibrosis. (2021) (2)
- Impact of a new simplified disability scoring system for adult patients with localized scleroderma (2018) (2)
- A statistical study of 55 patients with extramammary Paget's disease (2005) (2)
- Effect of platelet‐poor plasma from patients with neurofibromatosis on the growth of cultured neurofibroma‐derived fibroblast‐like cells (1992) (1)
- [Epidemiological study of systemic scleroderma in Tokyo based on application forms for financial aid for patients with intractable diseases]. (1988) (1)
- [The correlations of respiratory function tests, chest roentgenographic manifestations and respiratory symptoms in the patients with systemic sclerosis, using a scoring-method for symptoms]. (1990) (1)
- Characteristics of Japanese patients with eosinophilic fasciitis: A brief multicenter study (2020) (1)
- Effects of transforming growth factor beta, gamma-interferon and histamine on cultured keloid fibroblasts (1993) (1)
- Four Cases of Bullous Pemphigoid Successfully Treated by Tetracycline and Niacinamide. (2001) (1)
- Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort. (2021) (1)
- Eosinophilia-myalgia syndrome : a report of two cases in Japan (1996) (1)
- HypersensitivityRepeated Elicitation of Contact by Preventing Mast Cell Recruitment in Immediate-Type Hypersensitivity Response L-Selectin or ICAM-1 Deficiency Reduces an (2003) (1)
- Elevated Serum BAFF Levels in Patients with Systemic Sclerosis (SSc): Enhanced BAFF Signaling in SSc B Lymphocytes (2016) (1)
- N-terminal Connective Tissue Growth Factor (CTGF) Is A Potential Biomarker Of Idiopathic Interstitial Pneumonias (IIPs) (2010) (1)
- [Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung]. (1986) (1)
- Systemic Sclerosis Up To Date (Special Issue) (2010) (1)
- Scaleroderma and the similar disease. (2 ) . Points of diagnosis and treatment not written in textbooks. (1998) (1)
- Study of clinical availability of urapidil for Raynaud phenomenon in systemic scaleroderma. (1994) (1)
- A case of juvenile localized scleroderma with anti-topoisomerase I antibody (2019) (1)
- [Immunologic abnormalities in localized scleroderma]. (1984) (1)
- Problems Associated with Inadequate Treatment for Atopic Dermatitis (2002) (1)
- BLNK expression is essential for IL-10 production in regulatory B cells that inhibit contact hypersensitivity (2013) (1)
- Hydrochyloric acid treatment of Hep‐2 cells for the detection of masked anticentromere antibody (ACA) (1991) (1)
- Human case of subcutaneous nodule because of a novel genetic variation of Dirofilaria sp. (2019) (1)
- [Mechanism of the development of fibrosis in dermal and visceral sclerosis]. (2001) (0)
- 13.19 Role of gated myocardial perfusion SPECT in systemic sclerosis compared with electrocardiography and 1-123 meta-iodobenzylguanidine (MIBG) scintigraphy (2001) (0)
- Scleroderma and autoantibodies (1995) (0)
- Successful radiation therapy for primary cutaneous follicle center lymphoma (2019) (0)
- 304 Inhibition of p38 MAP kinase suppresses murine Sclerodermatous Chronic Graft-Versus-Host Disease (2017) (0)
- Mechanism of fibrosis in skin and splanchnosclerosis. (2001) (0)
- Antiubiquitin antibody inlocalised andsystemic scleroderma (1996) (0)
- [Antinuclear antibodies and clinical signs in systemic scleroderma--relationship to score diagnosis]. (1985) (0)
- Serum Melanoma Inhibitory Activity (MIA) is a Useful Tumor Marker in Melanoma Patients (2003) (0)
- The Loss of MCP‐1 Attenuates Cutaneous Ischemic‐reperfusion Injury (2008) (0)
- A crucial role of L-selectin in C protein-induced experimental polymyositis of mice (2016) (0)
- Three Cases of Rheumatoid Arthritis which were Previously Misdiagnosed as Systemic Sclerosis (1998) (0)
- [Etiology of diffuse scleroderma--proposal of a hypothesis and subsequent development]. (1997) (0)
- Patch-stage mycosis fungoides associated with a swelling of the lower leg (2003) (0)
- Dual aspects of B cells in tumor immunity; B cells are capable of positive and negative regulation for tumor immunity against B16 melanoma (2017) (0)
- [A case of lepromatous type Hansen's disease]. (2003) (0)
- A case of dermatomyositis with the anti‐signal recognition particle antibody that was successfully treated with prednisolone and intravenous immunoglobulin therapy (2019) (0)
- Loss of heterozygosity of chromosome 9P21 and P16INK4a status in sporadic cutaneous melanoma (1998) (0)
- Esophageal dysmotility and gastroesophageal reflux symptom in patients with systemic sclerosis with endoscopically confirmed reflux esophagitis (2009) (0)
- Identification of ribonucleotide reductase mutation causing temperature-sensitivity of herpes simplex virus isolates from whitlow by deep sequencing (2015) (0)
- [Ultrastructural observation on cultured non-epidermal cells in Pringle's disease (II)]. (1982) (0)
- Pulmonary Dysfunction in Limites Cutaneous Systemic Sclerosis Patients with Anticentromere Antibody (2000) (0)
- [Notes on the characteristics of peculiar stroma cells in Pringle's disease (III). Changes in the DNA volumes analyzed by cytofluorometry]. (1982) (0)
- [Quantitative evaluation of esophageal scintigraphy in systemic sclerosis]. (2001) (0)
- Clinical usefulness of hydergine tablets for Raynaud phenomenon in scleroderma. (1996) (0)
- The Role of B Cells in Systemic Sclerosis (2016) (0)
- A case of Merkel cell carcinoma of the right big toe with Merkel cell polyomavirus infection (2016) (0)
- Etiology of pachydermia diffusa. Proposal of a hypothesis and afterward development. (1997) (0)
- [The titers and complement-activating abilities of anticentromere antibody in systemic sclerosis, other connective tissue diseases, and other related conditions]. (1991) (0)
- Three Cases of Mucous Membrane Pemphigoid: Usefulness of Various Local Therapies and Amniotic Membrane Transplantation (2012) (0)
- An Analysis of Atopic Dermatitis Patients Hospitalized for Treatment after Exacerbation Due to Inadequate Therapy without Topical Steroid (2002) (0)
- THU0006 Trans-ethnic meta-analysis of genome-wide association studies identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis (2017) (0)
- Site Molecule-1 Up-Regulation at the Elicitation Endothelial Intercellular Adhesion Contact Hypersensitivity by Abrogating Ultraviolet Light Exposure Suppresses (2003) (0)
- A CASE OF MCTD WITH URTICARIA‐LIKE LESIONS (1984) (0)
- Skin penetration of grepafloxacin and its clinical use in the treatment of skin and skin structure infection (1995) (0)
- [Antinuclear antibodies in localized scleroderma]. (1982) (0)
- 220 Induction of subcutaneous tissue fibrosis in newborn mice by simultaneous application of transforming growth factor β and basic fibroblast growth factor (1997) (0)
- The relationship between anti-epiligrin cicatricial pemphigoid and gastric carcinoma (1998) (0)
- Role of inducible costimulator and inducible costimulator ligand in bleomycin-induced lung and skin fibrosis model (94.22) (2009) (0)
- 002 Tumor-infiltrating CD5+ regulatory B1 cells suppress melanoma tumor immunity via inhibiting cytokine production of tumor-infiltrating CD8+ T cells (2018) (0)
- Chemotaxis in immunity (PP-029) (2010) (0)
- Cutaneous Mycobacterium chelonae infection in a rheumatoid arthritis patient treated with etanercept. (2013) (0)
- PI3K-Akt pathway modulates IL-10 producing regulatory B cell (2013) (0)
- (EUSTAR)Trials and Research group systemic sclerosis: a report from the EULAR EULAR recommendations for the treatment of (2009) (0)
- PATHOGENESIS OF SYSTEMIC SCLEROSIS AND CCN2 (CONNECTIVE TISSUE GROWTH FACTOR) (2005) (0)
- An examination of the risk factors associated with metastasis and local recurrence of cutaneous squamous cell carcinoma for patients with spinalioma (2011) (0)
- Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod (2019) (0)
- Transforming Growth Factor-ß and Connective Tissue Growth Factor (2016) (0)
- Questionnaire Survey on Diagnosis, Treatment, and Damage Caused by Quack Remedies for Infantile Atopic Dermatitis : A Fact-finding Inquiry in Registered Dermatologists and Pediatricians of Ishikawa Prefecture (1999) (0)
- A Follow-up Study of Skin Thickness in a Patient with Systemic Sclerosis Using an Ultrasound Apparatus. (1996) (0)
- Diagnosing Puffy Fingers in the Rheumatic Patient (2014) (0)
- A case of lymphoma-associated haemophagocytic syndrome in advanced-stage mycosis fungoides (2020) (0)
- S-1108 in the field of dermatology (1993) (0)
- Contents Vol. 223, 2011 (2012) (0)
- 521 DRB1 is the primary genetic locus contributing to susceptibility to dermatomyositis positive for anti-TIF1γ antibody in Japanese (2018) (0)
- Changes of immunological parameters after local injection of interferon-.BETA. in melanoma patients. (2001) (0)
- [Supplementary notes on behaviors of non-epidermal cells in Pringle disease (IV)--changes in DNA contents of the cells analyzed by flow cytofluorometry (II)]. (1983) (0)
- A case of anti‐OJ antibody‐positive polymyositis with marked muscle involvement and interstitial lung disease (2020) (0)
- 302 IL-17A plays a role in the expression of connective tissue growth factor in a newborn mice fibrosis model (2016) (0)
- THE 90TH ANNUAL MEETING OF THE JAPANESE DERMATOLOGICAL ASSOCIATION (JDA), APRIL 26–28, 1991, KYOTO, JAPAN (1992) (0)
- 007 IL-6-producing effector B cell promotes fibrosis in scleroderma, while IL-10-producing regulatory B cells suppresses it; BAFF inhibition modulating effector and regulatory B cell balance (2018) (0)
- 222 Genetic analyses of skin tumours developed in a patient with hereditary nonpolyposis colorectal cancer (HNPCC) (1997) (0)
- L-Selectin Expression Requires Intercellular Adhesion Molecule 1 The Cutaneous Reverse Arthus Reaction (2002) (0)
- Two cases of mixed connective tissue disease initially diagnosed as rheumatoid arthritis (1993) (0)
- 034 Changes in cell kinetics and the expression of p53 protein in hairless mouse epidermis treated with repeated UV-B exposures (1995) (0)
- Conditional deletion of GSK 3 β results in enhanced tissue repair and fibrogenesis in vivo via an endothelin-1-dependent mechanism (2006) (0)
- [Clinical evaluation methods in patients with systemic sclerosis]. (2002) (0)
- Establishment of an animal model for allergic granulomatous vasculitis by IgE-mediated cutaneous reverse passive arthus reaction: contribution of selectins and ICAM-1 (2007) (0)
- 155 Chromosome 9p21 alterations in primary and metastatic melanomas (1997) (0)
- COEXISTANCE OF MORPHEA AND SYSTEMIC SCLEROSIS. AUTHORS' REPLY (1994) (0)
- A case of psoriasis vulgaris with multiple squamous cell carcinomas that presented with right inguinal lymph node metastasis (2016) (0)
- A unique CD9+CD80+ regulatory B cell inhibits contact hypersensitivity response (2017) (0)
- Skin Manifestations in Rheumatologic Disorders (2010) (0)
- 228 A novel splenic B1 regulatory B cell subset with a unique CD9+CD80+ phenotype suppresses an allergic disease via PI3K-Akt pathway activation (2016) (0)
- FTY720 ameliorates murine Scl-cGVHD by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into the skin (P5153) (2013) (0)
- Two Cases of Rheumatoid Vasculitis. (1997) (0)
- The Kanazawa University experience with angiosaricoma of the scalp: The usefulness of docetaxel as an adjuvant treatment (2007) (0)
- [Supplementary notes on the peculiar features of non-epithelial cells disease. (V). Disturbed mitotic processes of the cells]. (1983) (0)
- Tight-Skin Mice Attenuates the Development of Skin Fibrosis Intercellular Adhesion Molecule-1 Deficiency (2007) (0)
- Anti‐Ribosomal P Protein Antibodies in a Japanese Patient with Systemic Sclerosis (1996) (0)
- The Journal of Rheumatology Increased serum interleukin 23 in patients with systemic sclerosis. (2007) (0)
- [Treatment of juvenile atopic dermatitis]. (2010) (0)
- Investigation of the Mechanisms of Pressure Ulcers Using a Cyclical Cutaneous Ischemic–reperfusion Injury Model (2007) (0)
- Comprar Systemic Sclerosis | Kazuhiko Takehara | 9784431557074 | Springer (2016) (0)
- nvestigation of the role of Rac 1 in a bleomycin-induced scleroderma model using fibroblast-specific Rac 1 knockout mice (2008) (0)
- A case of malignant melanoma of unknown origin with skin metastasis of achromasia. (1991) (0)
- A case of basal cell nevus syndrome complicated by upper jaw squamous cell carcinoma. (1993) (0)
- Systemic scaleroderma and related disease. (3 ). Point of diagnosis and treatment, not written in the textbook. (1998) (0)
- 045 Role of effector and regulatory B cells in patients with systemic sclerosis: IL-6 producing effector B cells associated with skin fibrosis (2019) (0)
- The inhibitor of p38 MAP kinase suppresses skin fibrosis in the sclerodermatous chronic GVHD (2016) (0)
- A case of anti-NXP2 antibody-positive dermatomyositis with improvement of clinical symptoms and disappearance of autoantibody after resection of uterine cancer (2020) (0)
- FTY720 ameliorates sclerodermatous chronic GVHD by expansion of splenic regulatory cells and inhibition of skin immune cell infiltration (2013) (0)
- Watermelon stomach and colon in a patient with diffuse cutaneous systemic sclerosis (2017) (0)
- Decreased growth response to endothelin-1 in scleroderma fibroblasts (1994) (0)
- A case of myxofibrosarcoma with lung metastasis (2016) (0)
- Pulmonary Hypertension Associated with Pulmonary Fibrosis: A Case of Systemic Sclerosis Successfully Treated with Bosentan (2006) (0)
- Asymptomatic myocardial damages detected by gated SPECT and MIBG imaging in patients with systemic sclerosis (2006) (0)
- A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in model mice of systemic sclerosis (50.31) (2009) (0)
- Impaired collagen gel contraction with cultured skin fibroblasts from patients with systemic sclerosis. (2000) (0)
- 164 The expression of connective tissue growth factor during wound healing (1997) (0)
- Squamous cell carcinoma of hand induced by occupational exposure to radiation. Report on 2 cases. (1999) (0)
- A Case of Systemic Sclerosis with Interstitial Pneumonia Successfully Treated with Intravenous Cyclophosphamide Therapy (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kazuhiko Takehara?
Kazuhiko Takehara is affiliated with the following schools:
